Parkside Financial Bank & Trust Acadia Pharmaceuticals Inc Transaction History
Parkside Financial Bank & Trust
- $976 Million
- Q3 2025
A detailed history of Parkside Financial Bank & Trust transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 314 shares of ACAD stock, worth $7,542. This represents 0.0% of its overall portfolio holdings.
Number of Shares
314
Previous 307
2.28%
Holding current value
$7,542
Previous $6,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ACAD
# of Institutions
377Shares Held
163MCall Options Held
1.46MPut Options Held
1.09M-
Baker Bros. Advisors LP New York, NY42.9MShares$1.03 Billion7.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$364 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$290 Million0.0% of portfolio
-
State Street Corp Boston, MA7.26MShares$174 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.14MShares$172 Million2.04% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.89B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...